.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Colorcon
Merck
Cerilliant
Mallinckrodt
Julphar
Accenture
Teva
AstraZeneca
Moodys

Generated: December 18, 2017

DrugPatentWatch Database Preview

TESLASCAN Drug Profile

« Back to Dashboard

When do Teslascan patents expire, and when can generic versions of Teslascan launch?

Teslascan is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in TESLASCAN is mangafodipir trisodium. Additional details are available on the mangafodipir trisodium profile page.

Summary for TESLASCAN

US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
Drug Prices:see details
DailyMed Link:TESLASCAN at DailyMed
Drug patent expirations by year for TESLASCAN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TESLASCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
Ge HealthcareTESLASCANmangafodipir trisodiumINJECTABLE;INJECTION020652-001Nov 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Johnson and Johnson
Accenture
Fish and Richardson
Citi
Queensland Health
Chubb
Covington
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot